Anti-metastatic agents predicated upon polyamine macrocylic conjugates

Abstract

Disclosed herein are novel motuporamine compounds that act as anti-metastatic agents with low toxicity and high anti-migration activity. The non-toxic, anti-metastatic agents may be given to patients with potential or actual metastatic cancers, such as pancreatic cancers, alone in combination with known and/or new therapies to help block the growth and spread of tumor(s).

What is claimed is: 
     
       1. A compound represented by the formula: 
       
         
           
           
               
               
           
         
         wherein x=1-6 0-6; 
         wherein y=3 or 4 or 5; 
         wherein z=3 or 4 or 5; 
       
       , or a pharmaceutically acceptable salt thereof. 
     
     
       2. The compound of  claim 1 , wherein the compound comprises structure 
       
         
           
           
               
               
           
         
       
       or a pharmaceutically acceptable salt thereof. 
     
     
       3. The compound of  claim 1 , wherein the compound comprises structure 
       
         
           
           
               
               
           
         
       
       or a pharmaceutically acceptable salt thereof. 
     
     
       4. A pharmaceutical composition comprising a compound of  claim 1  and a pharmaceutically acceptable carrier. 
     
     
       5. The pharmaceutical composition of  claim 4 , wherein the compound comprises compound (47a), 
       
         
           
           
               
               
           
         
       
       or a pharmaceutically acceptable salt thereof; or compound 
       
         
           
           
               
               
           
         
       
       (47b), or a pharmaceutically acceptable salt thereof. 
     
     
       6. A compound represented by the formula: 
       
         
           
           
               
               
           
         
       
       wherein x=0-6;
 wherein y=3 or 4 or 5; and 
 wherein z=3 or 4 or 5; 
 
       R=acyl, or alkyl, 
       or a pharmaceutically acceptable salt thereof. 
     
     
       7. The compound of  claim 6 , wherein x=1, y=z=3 and R=acetyl; or x=1, y=z=3 and R=Me. 
     
     
       8. A compound represented by the formula: 
       
         
           
           
               
               
           
         
       
       wherein x=0-6;
 wherein y=2-8; 
 
       R=hydrogen, acyl, or alkyl, or a pharmaceutically acceptable salt thereof. 
     
     
       9. The compound of  claim 8 , wherein x=1, y=3 and R=acetyl; or x=1, y=3 and R=methyl; or x=1, y=3 and R=ethyl, or a pharmaceutically acceptable salt thereof.